STOCK TITAN
  1. Home
  2. Sec-filings
  3. ORKA
  4. [144] Oruka Therapeutics, Inc. SEC Filing

Orka (NASDAQ: ORKA) holder outlines 21,000-share sale and recent 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Orka shareholder Joana Goncalves plans to sell 21,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with a proposed sale date of 07/15/2026 and an aggregate market value of $1,836,870.00. The shares are listed as acquired via exercise of stock options for cash.

Recent activity includes three 10b5-1 sales of Orka common stock: 7,000 shares on 06/15/2026 for $484,610.70, 947 shares on 06/15/2026 for $65,996.43, and 7,000 shares on 05/15/2026 for $432,935.30.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 21,000 shares Common stock planned for sale on 07/15/2026
Aggregate market value of planned sale $1,836,870.00 Value associated with 21,000 Orka common shares
10b5-1 sale on 06/15/2026 7,000 shares for $484,610.70 Orka common stock sold under 10b5-1
Additional 10b5-1 sale on 06/15/2026 947 shares for $65,996.43 Separate Orka common stock sale
10b5-1 sale on 05/15/2026 7,000 shares for $432,935.30 Earlier Orka common stock transaction
Form 144 regulatory
"144: Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for JOANA GONCALVES 855 Oak Grove Avenue Suite 100"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Exercise of Stock Options financial
"Common | 07/15/2026 | Exercise of Stock Options | Issuer"
aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC Executive Financial Services 1 New"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What stock sale is planned by Joana Goncalves for Orka (ORKA)?
Joana Goncalves plans to sell 21,000 shares of Orka common stock. The planned transaction is listed with an aggregate market value of $1,836,870.00, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

When is the planned Orka (ORKA) share sale by Joana Goncalves scheduled?
The planned sale of Orka shares is scheduled for 07/15/2026. The notice lists this as the proposed date of sale for the 21,000 common shares to be traded on the NASDAQ market.

What is the aggregate market value of the planned Orka (ORKA) share sale?
The aggregate market value of the planned Orka share sale is $1,836,870.00. This value corresponds to the proposed sale of 21,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

How were the Orka (ORKA) shares to be sold by Joana Goncalves acquired?
The Orka shares to be sold were acquired through an exercise of stock options. The notice describes the acquisition as an exercise of stock options from the issuer, with consideration paid in cash in connection with the 21,000-share position.

What Orka (ORKA) 10b5-1 sales has Joana Goncalves made in the past three months?
Three 10b5-1 sales are listed: 7,000 shares on 06/15/2026 for $484,610.70, 947 shares on 06/15/2026 for $65,996.43, and 7,000 shares on 05/15/2026 for $432,935.30, all in Orka common stock.

Which firm is listed for handling the planned Orka (ORKA) stock sale?
The sale is listed through Morgan Stanley Smith Barney LLC Executive Financial Services. The address provided is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction involves Orka common stock on the NASDAQ market.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR